2017
DOI: 10.1016/j.biopha.2016.11.061
|View full text |Cite
|
Sign up to set email alerts
|

Anti-inflammatory effect of miltirone on inflammatory bowel disease via TLR4/NF-κB/IQGAP2 signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
30
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 21 publications
0
30
0
Order By: Relevance
“…Inflammatory cells and the secretion of related inflammatory mediators play critical roles in the development and progression of UC [ 25 ]. NF-κB, a key factor in the immune system, regulates the expression of several proinflammatory factors, such as TNF-α, IL-4, IL-6, COX-2, adhesion molecule-1 and chemokines.…”
Section: Discussionmentioning
confidence: 99%
“…Inflammatory cells and the secretion of related inflammatory mediators play critical roles in the development and progression of UC [ 25 ]. NF-κB, a key factor in the immune system, regulates the expression of several proinflammatory factors, such as TNF-α, IL-4, IL-6, COX-2, adhesion molecule-1 and chemokines.…”
Section: Discussionmentioning
confidence: 99%
“…70 As key pro-inflammatory mediators, TNF-α, IL-8, IL-1β, and IL-6 cause intestinal mucosal impairment resulting in inflammation. 70,71 Elevated levels of the pro-inflammatory cytokines, such as IL-1β and TNF-α, are present in the gut mucosa of patients suffering from UC. The cytokines TNF-α and IL-1β have been intimately related to the stimulation of the production of IL-8 during the pathogenesis of UC.…”
Section: Figurementioning
confidence: 99%
“…83 TLR4/NF-κB pathway has been found to be closely related to the immune system and anti-inflammatory signaling pathways, in recent years. 71 The MyD88-dependent TLR4 signaling pathway is one of major signaling pathways in stimulating the production of NF-κB by activating TRAF6. 33 As a member of the toll-like receptors (TLRs) family, TLR4 can mediate the transport of signal factors across the plasma membrane.…”
Section: Figurementioning
confidence: 99%
“…Current therapies for against IBD are limited by high costs, high toxicities and undesirable side effects (de Souza Ara ujo et al 2016;Wang et al 2017). This emphasizes the need to search for novel therapeutic options.…”
Section: Introductionmentioning
confidence: 99%